8281 (8281) Fair Value & Analysis

Consumer Defensive · Market cap HK$229M

8 8281 8281 · HK

PriceHK$0.2280

Fair ValueHK$0.2500

Upside+9.6%

Quality74/100

Watch 8281 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$0.1900 – HK$0.3100

Fair value as of: Jul 2, 2026

From 21 valuation models · updated today

Share price −8.8% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0550 – HK$0.3300 · fair‑value band HK$0.1900 – HK$0.3100 · the HK$0.2280 price screens below the HK$0.2500 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8281 (8281) currently trades at HK$0.2280, while our model-based Fair Value estimate is HK$0.2500 — implying the stock looks roughly 9.6% undervalued today. We read business quality at 74/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 8281 generated revenue of HK$269M at a net margin of 3.8%. Revenue declined 0.9% year over year. It earns a return on equity of 3.8%. The balance sheet holds a net cash position of HK$90.5M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$269M

Revenue growth (YoY) -0.9%

Net margin 3.8%

Return on equity 3.8%

Free cash flow HK$14.1M FY2025

P/E ratio 22.9

More key figures

Operating margin 6.9%

EPS growth (YoY) +45.8%

Net cash HK$90.5M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

8281 reported revenue of HK$269M in FY2025 versus HK$296M in FY2021, a compound −2.4%/yr. Reported net income was HK$10.2M in FY2025, compounding −5.6%/yr from FY2021.

Revenue −2.4%/yr

FY21 HK$296M

FY22 HK$271M

FY23 HK$292M

FY24 HK$261M

FY25 HK$269M

Net income −5.6%/yr

FY21 HK$12.8M

FY22 HK$12.2M

FY23 HK$7.1M

FY24 HK$3.0M

FY25 HK$10.2M

Is 8281 fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
PG PG	2,590 MXN	108.66 MXN	-96%
The Procter & Gamble Company PGCO34	R$54.71	R$7.69	-86%
L'Oréal S.A LRLCF	$445.77	$275.67	-38%
Unilever PLC UNLYF	$59.34	$46.11	-22%
Colgate-Palmolive Company CPA	€79.16	€55.96	-29%
Hindustan Unilever Limited HINDUNILVR	₹2,185	₹1,000	-54%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 8281 (8281) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.2500 versus a price of HK$0.2280 — about +10% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 8281?

Our model-based fair value for 8281 is HK$0.2500 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2280.

What is the quality score of 8281?

8281 has a Quality Score of 74/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 8281 (8281)?

8281 reported trailing-twelve-month revenue of about HK$269M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 8281?

The net profit margin of 8281 is about 3.8%, meaning it keeps roughly 3.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.